Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer

Tracy L. Rose, Michael R. Harrison, Allison M. Deal, Sundhar Ramalingam, Young E. Whang, Blaine Brower, Mary Dunn, Chelsea K. Osterman, Hillary M. Heiling, Marc A. Bjurlin, Angela B. Smith, Matthew E. Nielsen, Hung Jui Tan, Eric Wallen, Michael E. Woods, Daniel George, Tian Zhang, Anthony Drier, William Y. Kim, Matthew I. Milowsky

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

Sort by
Weight
Alphabetically

Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer

Fingerprint

Medicine & Life Sciences